Castleark Management’s West Pharmaceutical WST Stock Holding History

Castleark Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-25,105	Closed	-$2.46M	–	408
2018 Q4	$2.46M	Sell	25,105 -18,650	-43%	-$2.02M	0.1%	203
2018 Q3	$5.4M	Buy	+43,755	New	+$4.91M	0.16%	189
2017 Q4	–	Sell	-34,985	Closed	-$3.37M	–	445
2017 Q3	$3.37M	Buy	+34,985	New	+$3.17M	0.11%	222
2016 Q4	–	Sell	-149,985	Closed	-$11.2M	–	424
2016 Q3	$11.2M	Sell	149,985 -9,110	-6%	-$723K	0.34%	82
2016 Q2	$12.1M	Sell	159,095 -29,005	-15%	-$2.11M	0.39%	71
2016 Q1	$13M	Buy	+188,100	New	+$11.3M	0.41%	62

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Castleark Management's WST Position: Q1 2019 in Review

Castleark Management sold out of West Pharmaceutical (WST) in Q1 2019, closing a stake of 25,105 shares — an estimated $2.46M sold.

Castleark Management first reported a position in WST in Q1 2016 and held it in 6 quarters. The position peaked at $13M in Q1 2016. 379 funds tracked by Wall St. Rank hold WST as of Q1 2019.

Castleark Management reported no remaining West Pharmaceutical position as of Q1 2019 after selling out during the quarter.
Castleark Management sold 25,105 West Pharmaceutical shares in Q1 2019, an estimated $2.46M.
Castleark Management first reported a position in West Pharmaceutical in Q1 2016 and held it in 6 quarters.
Castleark Management's West Pharmaceutical position peaked at $13M in Q1 2016.
379 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2019.

Based on Castleark Management's 13F filing for Q1 2019, filed 14 May 2019.